|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1015935516 |
003 |
DE-627 |
005 |
20230918205829.0 |
007 |
cr uuu---uuuuu |
008 |
181112s2017 xxk|||||o 00| ||eng c |
016 |
7 |
|
|a GBB832324
|2 UK
|
020 |
|
|
|a 9781786392404
|c ePDF
|9 978-1-78639-240-4
|
020 |
|
|
|a 9781786392411
|c ePub
|9 978-1-78639-241-1
|
024 |
7 |
|
|a 10.1079/9781786392398.0000
|2 doi
|
035 |
|
|
|a (DE-627)1015935516
|
035 |
|
|
|a (DE-576)513606610
|
035 |
|
|
|a (DE-599)GBV1015935516
|
035 |
|
|
|a (OCoLC)1232472072
|
035 |
|
|
|a (EBP)061233544
|
035 |
|
|
|a (CABI)10.1079/9781786392398.0000
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
041 |
|
|
|a eng
|
044 |
|
|
|c XA-GB
|
050 |
|
0 |
|a RM666.H33
|
060 |
|
0 |
|a WB 438
|
082 |
0 |
|
|a 615.321
|
082 |
0 |
|
|a 615.3/21
|q LOC
|2 23
|
084 |
|
|
|a ZE 29800
|2 rvk
|0 (DE-625)rvk/155832:
|
084 |
|
|
|a VW 6100
|2 rvk
|0 (DE-625)rvk/147780:253
|
084 |
|
|
|a VW 5300
|2 rvk
|0 (DE-625)rvk/147765:253
|
245 |
1 |
0 |
|a Health benefits of green tea
|b an evidence-based approach$eedited by Yukihiko Hara (Editor in Chief), Chung S. Yang, Mamoru Isemura, and Isao Tomita
|
264 |
|
1 |
|a Wallingford, Oxfordshire
|a Boston, MA
|b CABI
|c [2017]
|
300 |
|
|
|a 1 Online-Ressource (xiv, 246 Seiten)
|b Diagramme
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a CABI Books
|
500 |
|
|
|a Includes bibliographical references and index
|
506 |
|
|
|a Access limited to subscribing institution.
|
520 |
|
|
|a This book provides evidence to support the health-promoting components of green tea for human health. Consisting of 27 chapters, it explores the significance of green tea and its catechins represented by epigallocatechin gallate, demonstrating their beneficial effects on diseases including cancer, obesity, metabolic syndrome, cardiovascular diseases, cerebrovascular disorders, atherosclerosis, diabetes, bacterial and viral diseases, hepatitis, dementia, and neurodegenerative diseases. The present status of human studies and avenues for future research are discussed. It is written by a team of experts from across the globe and makes significant Japanese findings available to international researchers. It is an essential resource for researchers interested in the biochemistry and pharmacology of green tea, and functional foods and beverages.
|
650 |
|
0 |
|a Green tea
|x Health aspects
|
650 |
|
0 |
|a Green tea
|x Therapeutic use
|
650 |
|
0 |
|a Green tea
|x Therapeutic use
|
650 |
|
0 |
|a Anticancer properties
|
650 |
|
0 |
|a Anticarcinogenic properties
|
650 |
|
0 |
|a Antineoplastic properties
|
650 |
|
0 |
|a Antioxidant properties
|
650 |
|
0 |
|a Antioxidants
|
650 |
|
0 |
|a Atherosclerosis
|
650 |
|
0 |
|a Bacterial diseases
|
650 |
|
0 |
|a Body fat
|
650 |
|
0 |
|a Brain
|
650 |
|
0 |
|a Cardiovascular diseases
|
650 |
|
0 |
|a Central nervous system
|
650 |
|
0 |
|a Cerebrovascular disorders
|
650 |
|
0 |
|a Chemical composition
|
650 |
|
0 |
|a Dementia
|
650 |
|
0 |
|a Diabetes mellitus
|
650 |
|
0 |
|a Epigallocatechin gallate
|
650 |
|
0 |
|a Flavanols
|
650 |
|
0 |
|a Functional foods
|
650 |
|
0 |
|a Hepatitis
|
650 |
|
0 |
|a Human diseases
|
650 |
|
0 |
|a Liver
|
650 |
|
0 |
|a Liver diseases
|
650 |
|
0 |
|a Medicinal properties
|
650 |
|
0 |
|a Metabolic disorders
|
650 |
|
0 |
|a Metabolic syndrome
|
650 |
|
0 |
|a Neoplasms
|
650 |
|
0 |
|a Nervous system diseases
|
650 |
|
0 |
|a Obesity
|
650 |
|
0 |
|a Pathogens
|
650 |
|
0 |
|a Phytochemicals
|
650 |
|
0 |
|a Tea
|
650 |
|
0 |
|a Tea (beverage)
|
650 |
|
0 |
|a Viral diseases
|
650 |
|
0 |
|a Viral hepatitis
|
650 |
|
0 |
|a Green tea
|
650 |
|
0 |
|a mammals
|
650 |
|
0 |
|a anti-carcinogenic properties
|
650 |
|
0 |
|a neurodegenerative diseases
|
650 |
|
0 |
|a animals
|
650 |
|
0 |
|a bacterial infections
|
650 |
|
0 |
|a Camellia sinensis
|
650 |
|
0 |
|a primates
|
650 |
|
0 |
|a Bacteria
|
650 |
|
0 |
|a fatness
|
650 |
|
0 |
|a OECD Countries
|
650 |
|
0 |
|a Ericales
|
650 |
|
0 |
|a Asia
|
650 |
|
0 |
|a angiosperms
|
650 |
|
0 |
|a Japan
|
650 |
|
0 |
|a Camellia
|
650 |
|
0 |
|a cerebrum
|
650 |
|
0 |
|a APEC countries
|
650 |
|
0 |
|a metabolic diseases
|
650 |
|
0 |
|a Theaceae
|
650 |
|
0 |
|a CNS
|
650 |
|
0 |
|a vertebrates
|
650 |
|
0 |
|a anti-cancer properties
|
650 |
|
0 |
|a bacterioses
|
650 |
|
0 |
|a anti-oxidant properties
|
650 |
|
0 |
|a prokaryotes
|
650 |
|
0 |
|a viral infections
|
650 |
|
0 |
|a radical scavenging properties
|
650 |
|
0 |
|a Homo
|
650 |
|
0 |
|a neuropathy
|
650 |
|
0 |
|a bacterium
|
650 |
|
0 |
|a cancers
|
650 |
|
0 |
|a Chordata
|
650 |
|
0 |
|a eukaryotes
|
650 |
|
0 |
|a viruses
|
650 |
|
0 |
|a Hominidae
|
650 |
|
0 |
|a eudicots
|
650 |
|
0 |
|a Spermatophyta
|
650 |
|
0 |
|a arteriosclerosis
|
650 |
|
0 |
|a East Asia
|
650 |
|
0 |
|a man
|
650 |
|
0 |
|a anti-neoplastic properties
|
650 |
|
0 |
|a plants
|
650 |
|
0 |
|a Developed Countries
|
650 |
|
2 |
|a Tea
|
650 |
|
2 |
|a Camellia sinensis
|
650 |
|
2 |
|a Catechin
|x therapeutic use
|
650 |
|
2 |
|a Phytotherapy
|x methods
|
650 |
|
4 |
|a Green tea
|x Health aspects
|
650 |
|
4 |
|a Green tea
|
650 |
|
4 |
|a Anticarcinogenic properties
|
650 |
|
4 |
|a Antineoplastic properties
|
650 |
|
4 |
|a Antioxidant properties
|
650 |
|
4 |
|a Antioxidants
|
650 |
|
4 |
|a Atherosclerosis
|
650 |
|
4 |
|a Bacterial diseases
|
650 |
|
4 |
|a Body fat
|
650 |
|
4 |
|a Brain
|
650 |
|
4 |
|a Cardiovascular diseases
|
650 |
|
4 |
|a Central nervous system
|
650 |
|
4 |
|a Cerebrovascular disorders
|
650 |
|
4 |
|a Chemical composition
|
650 |
|
4 |
|a Dementia
|
650 |
|
4 |
|a Diabetes mellitus
|
650 |
|
4 |
|a Epigallocatechin gallate
|
650 |
|
4 |
|a Flavanols
|
650 |
|
4 |
|a Functional foods
|
650 |
|
4 |
|a Anticancer properties
|
650 |
|
4 |
|a Hepatitis
|
650 |
|
4 |
|a Human diseases
|
650 |
|
4 |
|a Liver
|
650 |
|
4 |
|a Liver diseases
|
650 |
|
4 |
|a Medicinal properties
|
650 |
|
4 |
|a Metabolic disorders
|
650 |
|
4 |
|a Metabolic syndrome
|
650 |
|
4 |
|a Neoplasms
|
650 |
|
4 |
|a Nervous system diseases
|
650 |
|
4 |
|a Obesity
|
650 |
|
4 |
|a Pathogens
|
650 |
|
4 |
|a Phytochemicals
|
650 |
|
4 |
|a Tea
|
650 |
|
4 |
|a Tea (beverage)
|
650 |
|
4 |
|a Viral diseases
|
650 |
|
4 |
|a Viral hepatitis
|
689 |
0 |
0 |
|D s
|0 (DE-588)4158355-3
|0 (DE-627)105493635
|0 (DE-576)209841583
|a Grüner Tee
|2 gnd
|
689 |
0 |
1 |
|D s
|0 (DE-588)4288415-9
|0 (DE-627)104227516
|0 (DE-576)210822937
|a Naturheilmittel
|2 gnd
|
689 |
0 |
|
|5 (DE-627)
|
689 |
1 |
0 |
|D s
|0 (DE-588)4158355-3
|0 (DE-627)105493635
|0 (DE-576)209841583
|a Grüner Tee
|2 gnd
|
689 |
1 |
1 |
|D s
|0 (DE-588)4020754-7
|0 (DE-627)104658827
|0 (DE-576)208934650
|a Gesundheit
|2 gnd
|
689 |
1 |
|
|5 (DE-627)
|
700 |
1 |
|
|a Hara, Yukihiko
|d 1943-
|e herausgeberin
|0 (DE-588)1146308507
|0 (DE-627)1007838922
|0 (DE-576)183684923
|4 edt
|
700 |
1 |
|
|a Yang, Chung S.
|e herausgeberin
|4 edt
|
700 |
1 |
|
|a Isemura, Mamoru
|e herausgeberin
|4 edt
|
700 |
1 |
|
|a Tomita, Isao
|e herausgeberin
|4 edt
|
776 |
1 |
|
|z 9781786392398
|
776 |
1 |
|
|z 9781786392404
|
776 |
0 |
8 |
|i Erscheint auch als
|n Druckausgabe
|t Health benefits of green tea
|d Wallingford, Oxfordshire ; Boston, MA : CABI, [2017]
|
856 |
4 |
0 |
|u https://doi.org/10.1079/9781786392398.0000
|m X:CABI
|x Resolving-System
|z lizenzpflichtig
|
856 |
4 |
0 |
|u https://www.cabidigitallibrary.org/doi/book/10.1079/9781786392398.0000
|m X:CABI
|x Verlag
|z lizenzpflichtig
|
856 |
4 |
2 |
|u http://www.gbv.de/dms/bowker/toc/9781786392398.pdf
|m V:DE-601
|m X:Bowker
|q application/pdf
|v 2019-01-31
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
912 |
|
|
|a ZDB-91-CABI1
|b 2017
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a ISIL_DE-3
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_252
|
912 |
|
|
|a GBV_ILN_252_i00e
|
912 |
|
|
|a GBV_ILN_285
|
912 |
|
|
|a ISIL_DE-517
|
912 |
|
|
|a GBV_ILN_2026
|
912 |
|
|
|a ISIL_DE-100
|
935 |
|
|
|i Blocktest
|
936 |
r |
v |
|a ZE 29800
|b Tee
|k Agrar- und Forstwissenschaft, Gartenbau, Ernährungs- und Haushaltswissenschaft
|k Agrarprodukte und Agrarrohstoffe
|k Genussmittel, Genussmittelindustrie
|k Tee
|0 (DE-627)1271119110
|0 (DE-625)rvk/155832:
|0 (DE-576)201119110
|
936 |
r |
v |
|a VW 6100
|b Allgemeines
|k Chemie und Pharmazie
|k Pharmazeutische Biologie
|k Pharmazeutische Biologie allgemein
|k Nutzpflanzen der Tropen und Subtropen
|k Allgemeines
|0 (DE-627)1271841428
|0 (DE-625)rvk/147780:253
|0 (DE-576)201841428
|
936 |
r |
v |
|a VW 5300
|b Allgemeines
|k Chemie und Pharmazie
|k Pharmazeutische Biologie
|k Pharmazeutische Biologie allgemein
|k Phytochemie Pflanzeninhaltsstoff allgemein Chemotaxonomie
|k Allgemeines
|0 (DE-627)1271534045
|0 (DE-625)rvk/147765:253
|0 (DE-576)201534045
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 615.321
|
953 |
|
|
|2 045F
|a 615.3/21
|
980 |
|
|
|2 65
|1 01
|x 0003
|b 3842338880
|h CAB-Archive
|k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt.
|y k3o
|z 25-01-21
|
980 |
|
|
|2 252
|1 01
|x 4252
|b 1759529281
|c 00
|f BMEL
|d Online-Ressource
|e --%%--
|j --%%--
|k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.
|y zi00e
|z 15-03-18
|
980 |
|
|
|2 285
|1 01
|x 0517
|b 4377563114
|h OLR-CAB-TEST
|k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt.
|y z
|z 18-09-23
|
980 |
|
|
|2 2026
|1 01
|x DE-100
|b 3392784370
|c 00
|f --%%--
|d --%%--
|e --%%--
|j en
|y l01
|z 12-11-18
|
981 |
|
|
|2 65
|1 01
|x 0003
|r https://doi.org/10.1079/9781786392398.0000
|
981 |
|
|
|2 252
|1 01
|x 4252
|y E-books (CABI)
|r https://doi.org/10.1079/9781786392398.0000
|z ZZ
|
981 |
|
|
|2 285
|1 01
|x 0517
|r https://doi.org/10.1079/9781786392398.0000
|
981 |
|
|
|2 2026
|1 01
|x DE-100
|r https://doi.org/10.1079/9781786392398.0000
|
982 |
|
|
|2 252
|1 01
|x 4252
|8 00
|a Elektronisches Buch
|
995 |
|
|
|2 65
|1 01
|x 0003
|a CAB-Archive
|
995 |
|
|
|2 285
|1 01
|x 0517
|a OLR-CAB-TEST
|
998 |
|
|
|2 252
|1 01
|x 4252
|0 2018-03-15
|a Neuerwerbung
|